Venkat Chintareddy

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

BioCryst Pharmaceuticals (United States)(Current)

Venkat Chintareddy is an author at BioCryst Pharmaceuticals (United States) specializing in pharmacotherapy, phase iii clinical trials, and oral treatment.

Publications per year

2021–2024

Publications

Berotralstat (BCX7353): Structure-Guided Design of a Potent, Selective, and Oral Plasma Kallikrein Inhibitor to Prevent Attacks of Hereditary Angioedema (HAE)

Pravin L. Kotian, Minwan Wu, Satish Vadlakonda et al. · Journal of Medicinal Chemistry · 2021 · 31 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Design, Synthesis, and Investigation of the Pharmacokinetics and Anticancer Activities of Indenoisoquinoline Derivatives That Stabilize the G-Quadruplex in the <i>MYC</i> Promoter and Inhibit Topoisomerase I

Yichen Han, Adam J. Buric, Venkat Chintareddy et al. · Journal of Medicinal Chemistry · 2024 · 18 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

1–2 of 2